Lv1
70 积分 2024-01-28 加入
Co-opting Innate and Adaptive Immunity against Cancer
1个月前
已关闭
ARHGEF17/TEM4 regulates the cell cycle through control of G1 progression
1个月前
已完结
From tumour heterogeneity to advances in precision treatment of colorectal cancer
2个月前
已完结
人工智能在我国消化内镜领域的研究现状和展望
7个月前
已完结
Safety and efficacy of apatinib in combination with chemotherapy with or without immunotherapy versus chemotherapy alone as first-line treatment for advanced gastric cancer
7个月前
已完结
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
10个月前
已完结
[Chinese expert consensus on diagnosis and treatment of neurologic immune-related adverse events associated with immune checkpoint inhibitors (2022 edition)]
1年前
已完结
Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in China
1年前
已完结
Standard for diagnosis and treatment of primary liver cancer (2022 edition)
1年前
已关闭
A “Closed‐Loop” Therapeutic Strategy Based on Mutually Reinforced Ferroptosis and Immunotherapy
1年前
已完结
皖公网安备34019202002308
